Analyst Profile

Followed by 11 followers
.
Vikram Purohit

Vikram Purohit

Morgan Stanley
Wall Street Analyst
#7,896 out of 8,141 Wall Street Analysts
#23,553 out of 24,284 experts

Success Rate

16%
8 out of 49 transactions made a profit

Average Return

-23.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Vikram Purohit's trades since 2020 and holding each position for 1 Year would result in 16.33% of your transactions generating a profit, with an average return of -23.9% per rating.

Stock Rating Distribution

143Ratings
62.24% Hold
32.87% Buy
4.90% Sell
Distribution of Vikram Purohit's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Pandion Therapeutics, Inc.
(PAND)
Rating:Buy
Date:Aug 11, 2020 - Feb 25, 2021
Return:+217.20%
The most profitable rating made by Vikram Purohit

Vikram Purohit's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
NTGN
Neon Therapeutics
Jan 16, 2020
Hold
Upgraded
3Ratings
0%
-45.05%
Cogent Biosciences
Mar 03, 2020
Hold
Downgraded
$2.00
(-82.19% Downside)
2Ratings
0%
-71.30%
PTLA
Portola Pharma
May 08, 2020
Hold
Reiterated
5Ratings
0.00%
DBV Technologies SA - American
Aug 05, 2020
Hold
Reiterated
$2.00
(36.99% Upside)
2Ratings
0.00%
PAND
Pandion Therapeutics
Feb 25, 2021
Hold
Downgraded
2Ratings
100%
+217.20%
TScan Therapeutics
Aug 10, 2021
Buy
Initiated
$22.00
(852.38% Upside)
1Ratings
0%
-62.40%
Hookipa Pharma
Nov 12, 2021
Hold
Downgraded
$6.00
(500.00% Upside)
3Ratings
0%
-53.40%
RDUS
Radius Health
Dec 10, 2021
Sell
Downgraded
$7.00
(-30.56% Downside)
7Ratings
0%
-40.07%
Theravance Biopharma
Jul 25, 2022
Sell
Reiterated
$10.00
(-4.67% Downside)
12Ratings
11%
-27.82%
Certara
Aug 24, 2022
Hold
Reiterated
$20.00
(26.82% Upside)
6Ratings
0.00%
List of latest recommendations made by Vikram Purohit. Click to expand and see Vikram Purohit's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >